ASAM Drug Testing Pocket Guide

Drug Testing Pocket Guide

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/840070

Contents of this Issue

Navigation

Page 14 of 35

15 Î All samples undergoing definitive testing should be tested for creatinine concentration, pH level and specific gravity (if creatinine is low). Signs of Urine Sample Tampering Î All urine samples should be checked for unusual specimen characteristics. Characteristics include: • Temperature outside the expected range of 90–100°F within 4 minutes of production (this can be checked using a heat sensitive strip). • Unusual color or smell, soapy appearance, cloudiness or particles floating in the liquid. Î If a urine sample exhibits unusual specimen characteristics, the sample should undergo specimen validity testing to help identify whether and how tampering occurred. Responding to Specimen Validity Test Results Î Providers should consider samples that have been tampered with to be presumptive positive. Î For patients with past incidences of dilute urine samples, it is advisable to collect samples in the morning or request that patients decrease water intake prior to sample collection. Î For patients with past incidences of dilute urine samples, use creative solutions, such as collecting before work, on days off, or use an alternative matrix. Urine Testing for Specific Substances Î Urine testing for the use of alcohol is appropriate with current clinical tools. Ethyl glucuronide (EtG) is an appropriate target metabolite when monitoring a patient for complete alcohol abstinence. • Ethanol-containing products, including hand sanitizers and mouthwash, should be avoided before an EtG test. Î Urine testing is helpful when assessing amphetamine use. Particular caution should be paid to the interpretation of amphetamine immunoassays due to known limitations in specificity. Î Urine testing is helpful when assessing benzodiazepine use. • Particular caution should be paid to the interpretation of benzodiazepine immunoassays due to known limitations in specificity. • Immunoassay results should be used cautiously when monitoring a patient's adherence to prescribed benzodiazepines. If a patient reports that he or she is taking the drug but a urine drug screen is negative, further analysis using definitive testing should be considered.

Articles in this issue

Archives of this issue

view archives of ASAM Drug Testing Pocket Guide - Drug Testing Pocket Guide